UnitedHealth shares have fallen over the past three months, but one Wall Street firm is looking for a rebound

UnitedHealth has fallen for more than three months, according to a market report that tied the pullback to a deterioration in membership and weaker near-term momentum even after the company posted a “beat-and-raise” quarter. The note said UnitedHealth shed members and that the stock slipped about 10% over the period, with shares closing lower on the earnings update.

The same report also emphasized that the selloff is colliding with a new, more optimistic view from a major Wall Street bank. It said the firm raised its target and argued that UnitedHealth could deliver roughly 40% gains from the prevailing level, framing that outlook around what the bank expects to change in the business unit’s direction.

While the market note did not spell out granular operating drivers in the excerpt provided, it suggested the bank’s confidence rests on a specific part of UnitedHealth’s portfolio. The report described the argument as centering on a “business unit most” (the remainder of that description was not provided), implying the firm is focused on performance that could improve even if the broader stock trend has been negative.

UnitedHealth’s earnings update, described in the note as a beat-and-raise quarter, is a key reason the stock decline has not fully eliminated optimism on Wall Street. When companies beat expectations and increase guidance, it can announcement that underlying fundamentals are holding up. In this case, however, the report paired that positive earnings momentum with continued pressure from membership trends.

For context, UnitedHealth operates through two major segments: UnitedHealthcare, its insurance and managed care arm that tracks enrollment and medical utilization, and Optum, which includes health services such as pharmacy benefit management, care delivery, and data and analytics. In managed care, membership flows can influence revenue stability and the pace at which risks and costs normalize, which can in turn move expectations for earnings durability.

The market report did not provide full details on the size and timing of the membership declines or how the bank quantified the upside. It also did not disclose whether the bank’s raised target was based on revised earnings estimates, multiple expansion, or a change in assumptions about medical cost trends and retention.

Still, the juxtaposition described in the note is familiar in healthcare equities: shares can fall on near-term operational indicates, while analysts keep pointing to later improvements supported by earnings guidance. In this case, the report’s “beat-and-raise” characterization suggests UnitedHealth’s leadership delivered enough to prevent the earnings update from becoming purely negative for the stock story, even as members were described as slipping.

Investors watching UnitedHealth next will likely focus on whether membership stabilization accelerates and whether the company’s medical cost and utilization metrics improve in line with the bank’s thesis. If subsequent disclosures show that the trends driving the stock decline are reversing, it would narrow the gap between the market’s near-term concerns and the bank’s longer-horizon expectations.